Literature DB >> 30537762

Electrochemotherapy in the Treatment of Breast Cancer Metastasis to the Skin and Subcutaneous Tissue - Multicenter Experience.

Mateusz Wichtowski, Dawid Murawa, Roman Czarnecki, Jacek Piechocki, Zbigniew Nowecki, Wojciech Witkiewicz.   

Abstract

INTRODUCTION: Breast cancer is responsible for more than 50% of cutaneous metastases. One of the treatment options is electrochemotherapy (ECT). It is an effective method of local tumor ablation through the application of electroporation. The primary objective of the study was to demonstrate a response to the treatment in our group of patients.
METHODS: Between February 2015 and October 2016, in 3 centers in Poland, 47 ECT procedures were performed in 38 patients with metastasis of breast cancer to the skin.
RESULTS: At 12 weeks after the procedures, 71% of patients showed a positive response to the treatment (42% with complete response, and 29% with partial response). Multivariate analysis demonstrated that only the estrogen receptor status and the size of the metastatic lesion were predictive of overall response (p = 0.0243 and p = 0.03716, respectively).
CONCLUSION: The results of our study demonstrate a high effectiveness of ECT in the treatment of cutaneous metastasis from breast cancer. This method, although used for palliative treatment, brings a significant improvement in the quality of life of patients.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Bleomycin; Breast neoplasms; Electrochemotherapy

Mesh:

Year:  2018        PMID: 30537762     DOI: 10.1159/000494093

Source DB:  PubMed          Journal:  Oncol Res Treat        ISSN: 2296-5270            Impact factor:   2.825


  5 in total

1.  Electrochemotherapy of skin metastases from breast cancer: a systematic review.

Authors:  Martina Ferioli; Anna Myriam Perrone; Milly Buwenge; Alessandra Arcelli; Alice Zamagni; Gabriella Macchia; Francesco Deodato; Savino Cilla; Luca Tagliaferri; Francesca De Terlizzi; Pierandrea De Iaco; Claudio Zamagni; Alessio Giuseppe Morganti
Journal:  Clin Exp Metastasis       Date:  2020-11-12       Impact factor: 5.150

2.  Synthesis, characterization, antioxidant and anticancer activities of a new Schiff base and its M(II) complexes derived from 5-fluorouracil.

Authors:  Ahmet Savcı; Kenan Buldurun; Mehmet Eşref Alkış; Yusuf Alan; Nevin Turan
Journal:  Med Oncol       Date:  2022-08-16       Impact factor: 3.738

3.  Modeling iontophoretic drug delivery in a microfluidic device.

Authors:  Maryam Moarefian; Rafael V Davalos; Danesh K Tafti; Luke E Achenie; Caroline N Jones
Journal:  Lab Chip       Date:  2020-09-01       Impact factor: 6.799

4.  The Role of Electrochemotherapy in the Cutaneous and Subcutaneous Metastases From Breast Cancer: Analysis of Predictive Factors to Treatment From an Italian Cohort of Patients.

Authors:  Francesco Russano; Paolo Del Fiore; Claudia Di Prata; Andrea Pasqual; Roberto Marconato; Luca Giovanni Campana; Romina Spina; Carlo Maria Gianesini; Alessandra Collodetto; Saveria Tropea; Luigi Dall'Olmo; Sabrina Carraro; Alessandro Parisi; Sara Galuppo; Giovanni Scarzello; Francesca De Terlizzi; Marco Rastrelli; Simone Mocellin
Journal:  Front Oncol       Date:  2021-12-21       Impact factor: 6.244

Review 5.  Electroporation and Electrochemotherapy in Gynecological and Breast Cancer Treatment.

Authors:  Zofia Łapińska; Urszula Szwedowicz; Anna Choromańska; Jolanta Saczko
Journal:  Molecules       Date:  2022-04-12       Impact factor: 4.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.